The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
Open accessAbstract
Background: Nanomedicine is a field of science that uses nanoscale materials for the diagnosis and treatment of human disease. It has emerged as an important aspect of the therapeutics, but at the same time, also raises concerns regarding the safety of the nanomaterials involved. Recent applications of functionalized biodegradable nanomaterials have significantly improved the safety profile of nanomedicine. Objective: Our goal is to evaluate different types of biodegradable nanomaterials that have been functionalized for their biomedical applications. Method: In this review, we used PubMed as our literature source and selected recently published studies on biodegradable nanomaterials and their applications in nanomedicine. Results: We found that biodegradable polymers are commonly functionalized for various purposes. Their property of being naturally degraded under biological conditions allows these biodegradable nanomaterials to be used for many biomedical purposes, including bio-imaging, targeted drug delivery, implantation and tissue engineering. The degradability of these nanoparticles can be utilized to control cargo release, by allowing efficient degradation of the nanomaterials at the target site while maintaining nanoparticle integrity at off-target sites. Conclusion: While each biodegradable nanomaterial has its advantages and disadvantages, with careful design and functionalization, biodegradable nanoparticles hold great future in nanomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 6×
“The degradation rate of PLGA can be changed by adjusting the ratio of PLA:PGA and their molecular weights in order to control the release of incorporated drugs [31,32].”
BackgroundInfluentialPLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Farah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Biomedical photoacoustic imaging
Beard, P. (2011) · Interface Focus · doi:10.1098/rsfs.2011.0028 · Cited by 2,205
Biodegradable synthetic polymers for tissue engineering
CSIRO Molecular Science, B. 1., & Gunatillake, P. (2003) · European Cells and Materials · doi:10.22203/ecm.v005a01 · Cited by 1,765
Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity
Manke, A., Wang, L., & Rojanasakul, Y. (2013) · BioMed Research International · doi:10.1155/2013/942916 · Cited by 1,727
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
PEGylated nanoparticles for biological and pharmaceutical applications
Otsuka, H., Nagasaki, Y., & Kataoka, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00226-0 · Cited by 1,588
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Mohammed, M., Syeda, J., Wasan, K., & Wasan, E. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040053 · Cited by 1,362
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Dendrimers: synthesis, applications, and properties
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati-Koshki, K., & Pashaei-Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,279
Nanotechnology: The new perspective in precision agriculture
Duhan, J. S., Kumar, R., Kumar, N., Kaur, P., Nehra, K., & Duhan, S. (2017) · Biotechnology Reports · doi:10.1016/j.btre.2017.03.002 · Cited by 1,232
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
Tyler, B., Gullotti, D., Mangraviti, A., Utsuki, T., & Brem, H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.018 · Cited by 1,050
Larrañeta, E., Lutton, R. E. M., Woolfson, A. D., & Donnelly, R. F. (2016) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2016.03.001 · Cited by 964
Stability of Chitosan—A Challenge for Pharmaceutical and Biomedical Applications
Szymańska, E., & Winnicka, K. (2015) · Marine Drugs · doi:10.3390/md13041819 · Cited by 942
The present and future of nanotechnology in human health care
Sahoo, S. K., Parveen, S., & Panda, J. J. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.11.008 · Cited by 905
Design of biodegradable, implantable devices towards clinical translation
Li, C., Guo, C., Fitzpatrick, V., Ibrahim, A., Zwierstra, M. J., Hanna, P., Lechtig, A., Nazarian, A., Lin, S. J., & Kaplan, D. L. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0150-z · Cited by 808
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Huang, P., Lin, J., Li, W., Rong, P., Wang, Z., Wang, S., Wang, X., Sun, X., Aronova, M., Niu, G., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201308986 · Cited by 672
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Recent applications of PLGA based nanostructures in drug delivery
Mir, M., Ahmed, N., & Rehman, A. U. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.038 · Cited by 621
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Liposomes: Technologies and Analytical Applications
Jesorka, A., & Orwar, O. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.112747 · Cited by 569
3D-Printed Biodegradable Microswimmer for Theranostic Cargo Delivery and Release
Ceylan, H., Yasa, I. C., Yasa, O., Tabak, A. F., Giltinan, J., & Sitti, M. (2019) · ACS Nano · doi:10.1021/acsnano.8b09233 · Cited by 558
Poly(lactic acid) blends in biomedical applications
Saini, P., Arora, M., & Kumar, M. N. V. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.014 · Cited by 549
Tapeinos, C., Battaglini, M., & Ciofani, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.033 · Cited by 539
PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
Grossen, P., Witzigmann, D., Sieber, S., & Huwyler, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.028 · Cited by 496
Contrast-induced kidney injury: mechanisms, risk factors, and prevention
Seeliger, E., Sendeski, M., Rihal, C. S., & Persson, P. B. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr494 · Cited by 478
Micelles and nanoparticles for ultrasonic drug and gene delivery
Husseini, G. A., & Pitt, W. G. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.008 · Cited by 468
Fu, L.-H., Hu, Y.-R., Qi, C., He, T., Jiang, S., Jiang, C., He, J., Qu, J., Lin, J., & Huang, P. (2019) · ACS Nano · doi:10.1021/acsnano.9b05836 · Cited by 437
Zuckerman, J. E., Gritli, I., Tolcher, A., Heidel, J. D., Lim, D., Morgan, R., Chmielowski, B., Ribas, A., Davis, M. E., & Yen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411393111 · Cited by 427
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Cancer drug delivery in the nano era: An overview and perspectives
Li, Z., Tan, S., Li, S., Shen, Q., & Wang, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5718 · Cited by 406
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation
Park, K., Skidmore, S., Hadar, J., Garner, J., Park, H., Otte, A., Soh, B. K., Yoon, G., Yu, D., Yun, Y., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.003 · Cited by 404
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
PEG–PLGA copolymers: Their structure and structure-influenced drug delivery applications
Zhang, K., Tang, X., Zhang, J., Lu, W., Lin, X., Zhang, Y., Tian, B., Yang, H., & He, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.026 · Cited by 374
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
Trivedi, R., & Kompella, U. B. (2010) · Nanomedicine · doi:10.2217/nnm.10.10 · Cited by 358 · cited 2×
“For example, in addition to conventional micelles with a hydrophobic core and a hydrophilic shell, there are also reverse micelles with a hydrophilic core and a hydrophobic shell to ensure sustained drug release through the hydrogen bond between the drug and the core [40].”
BackgroundLyu, Y., Zeng, J., Jiang, Y., Zhen, X., Wang, T., Qiu, S., Lou, X., Gao, M., & Pu, K. (2018) · ACS Nano · doi:10.1021/acsnano.7b08616 · Cited by 357
Rai, R., Alwani, S., & Badea, I. (2019) · Polymers · doi:10.3390/polym11040745 · Cited by 350
Lee, B. K., Yun, Y., & Park, K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.020 · Cited by 340
Customizing poly(lactic-co-glycolic acid) particles for biomedical applications
Swider, E., Koshkina, O., Tel, J., Cruz, L. J., de Vries, I. J. M., & Srinivas, M. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.04.006 · Cited by 328
Polymer-Based Nanomaterials and Applications for Vaccines and Drugs
Han, J., Zhao, D., Li, D., Wang, X., Jin, Z., & Zhao, K. (2018) · Polymers · doi:10.3390/polym10010031 · Cited by 327
Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications
Santos, A., Veiga, F., & Figueiras, A. (2019) · Materials · doi:10.3390/ma13010065 · Cited by 313
Nanotechnology research directions for societal needs in 2020: summary of international study
Roco, M. C., Mirkin, C. A., & Hersam, M. C. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0275-5 · Cited by 308
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Zhong, H., Chan, G., Hu, Y., Hu, H., & Ouyang, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040263 · Cited by 288
Production and clinical development of nanoparticles for gene delivery
Chen, J., Guo, Z., Tian, H., & Chen, X. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.23 · Cited by 274
Degradability of chitosan micro/nanoparticles for pulmonary drug delivery
Islam, N., Dmour, I., & Taha, M. O. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01684 · Cited by 274
Targeting atherosclerosis by using modular, multifunctional micelles
Peters, D., Kastantin, M., Kotamraju, V. R., Karmali, P. P., Gujraty, K., Tirrell, M., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903369106 · Cited by 271
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Zhou, Z., Qutaish, M., Han, Z., Schur, R. M., Liu, Y., Wilson, D. L., & Lu, Z.-R. (2015) · Nature Communications · doi:10.1038/ncomms8984 · Cited by 260
Shvedova, A. A., Kagan, V. E., & Fadeel, B. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105819 · Cited by 242
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications
Dave, V., Tak, K., Sohgaura, A., Gupta, A., Sadhu, V., & Reddy, K. R. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.03.017 · Cited by 241
Cheheltani, R., Ezzibdeh, R. M., Chhour, P., Pulaparthi, K., Kim, J., Jurcova, M., Hsu, J. C., Blundell, C., Litt, H. I., Ferrari, V. A., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.015 · Cited by 240
Recent Development of pH-Responsive Polymers for Cancer Nanomedicine
Tang, H., Zhao, W., Yu, J., Li, Y., & Zhao, C. (2018) · Molecules · doi:10.3390/molecules24010004 · Cited by 239
Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments
Karlsson, J., Vaughan, H. J., & Green, J. J. (2018) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060817-084055 · Cited by 235
Nanoparticles and The Blood Coagulation System. Part II: Safety Concerns
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2013) · Nanomedicine · doi:10.2217/nnm.13.49 · Cited by 228
Kim, S. Y., & Lee, Y. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00292-1 · Cited by 227
Liposomes and lipid bilayers in biosensors
Mazur, F., Bally, M., Städler, B., & Chandrawati, R. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.020 · Cited by 223
Future impact of nanotechnology on medicine and dentistry
Mehta, D., Patil, M., & Guvva, S. (2008) · Journal of Indian Society of Periodontology · doi:10.4103/0972-124x.44088 · Cited by 202
Derakhshandeh, K., Erfan, M., & Dadashzadeh, S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.09.004 · Cited by 200
Imaging and Nanomedicine in Inflammatory Atherosclerosis
Mulder, W. J. M., Jaffer, F. A., Fayad, Z. A., & Nahrendorf, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005101 · Cited by 192
A critical review of lipid-based nanoparticles for taxane delivery
Feng, L., & Mumper, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.006 · Cited by 191
Tam, J. M., Tam, J. O., Murthy, A., Ingram, D. R., Ma, L. L., Travis, K., Johnston, K. P., & Sokolov, K. V. (2010) · ACS Nano · doi:10.1021/nn9015746 · Cited by 186
PEG- b -PLA micelles and PLGA- b -PEG- b -PLGA sol–gels for drug delivery
Cho, H., Gao, J., & Kwon, G. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.015 · Cited by 186
Arginine functionalized peptide dendrimers as potential gene delivery vehicles
Luo, K., Li, C., Li, L., She, W., Wang, G., & Gu, Z. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.030 · Cited by 179
Polymer encapsulation of ruthenium complexes for biological and medicinal applications
Villemin, E., Ong, Y. C., Thomas, C. M., & Gasser, G. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0088-0 · Cited by 167
Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins
Han, Y., Gao, Z., Chen, L., Kang, L., Huang, W., Jin, M., Wang, Q., & Bae, Y. H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.004 · Cited by 164
Espinoza, S. M., Patil, H. I., San Martin Martinez, E., Casañas Pimentel, R., & Ige, P. P. (2020) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2018.1539990 · Cited by 162
Nanoparticle Therapy for Vascular Diseases
Flores, A. M., Ye, J., Jarr, K.-U., Hosseini-Nassab, N., Smith, B. R., & Leeper, N. J. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311569 · Cited by 161
Artificial intelligence in nanomedicine
Ho, D., Wang, P., & Kee, T. W. (2018) · Nanoscale Horizons · doi:10.1039/c8nh00233a · Cited by 158
The Newest Generation of Drug-eluting Stents and Beyond
Lee, D., & Hernández, J. M. D. L. T. (2018) · European Cardiology Review · doi:10.15420/ecr.2018:8:2 · Cited by 152
Lee, D., Bae, S., Hong, D., Lim, H., Yoon, J. H., Hwang, O., Park, S., Ke, Q., Khang, G., & Kang, P. M. (2013) · Scientific Reports · doi:10.1038/srep02233 · Cited by 148
Self-citationScientific basis of nanotechnology, implications for the food sector and future trends
Rossi, M., Cubadda, F., Dini, L., Terranova, M. L., Aureli, F., Sorbo, A., & Passeri, D. (2014) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2014.09.004 · Cited by 140
Ultrasmall-in-Nano Approach: Enabling the Translation of Metal Nanomaterials to Clinics
Cassano, D., Pocoví‐Martínez, S., & Voliani, V. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00664 · Cited by 137
Nanoencapsulation of Insulin into Zirconium Phosphate for Oral Delivery Applications
Díaz, A., David, A., Pérez, R. J., et al. (2010) · Biomacromolecules · doi:10.1021/bm100659p · Cited by 135
Andrabi, S. S., Yang, J., Gao, Y., Kuang, Y., & Labhasetwar, V. D. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.001 · Cited by 135
Wang, S., Kim, G., Lee, Y.-E. K., Hah, H. J., Ethirajan, M., Pandey, R. K., & Kopelman, R. (2012) · ACS Nano · doi:10.1021/nn301633m · Cited by 120
The use of nanotechnology in cardiovascular disease
Chandarana, M., Curtis, A. D. M., & Hoskins, C. (2018) · Applied Nanoscience · doi:10.1007/s13204-018-0856-z · Cited by 119
Biodegradation of poly(ε-caprolactone) in natural water environments
Heimowska, A., Morawska, M., & Bocho–Janiszewska, A. (2017) · Green Sciences · doi:10.1515/pjct-2017-0017 · Cited by 118
Polymer Micelles as Drug Carriers
Batrakova, E. V., Bronich, T. K., Vetro, J. A., & Kabanov, A. V. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0005 · Cited by 112
Anti-inflammatory Nanomedicine for Cardiovascular Disease
Katsuki, S., Matoba, T., Koga, J., Nakano, K., & Egashira, K. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00087 · Cited by 108
Combinatorial Nano–Bio Interfaces
Cai, P., Zhang, X., Wang, M., Wu, Y., & Chen, X. (2018) · ACS Nano · doi:10.1021/acsnano.8b03285 · Cited by 102
Hydrogen Peroxide‐Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury
Bae, S., Park, M., Kang, C., Dilmen, S., Kang, T. H., Kang, D. G., Ke, Q., Lee, S. U., Lee, D., & Kang, P. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003697 · Cited by 98
Self-citationLih, E., Kum, C. H., Park, W., Chun, S. Y., Cho, Y., Joung, Y. K., Park, K.-S., Hong, Y. J., Ahn, D. J., Kim, B., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02365 · Cited by 97
Sánchez‐González, S., Diban, N., & Urtiaga, A. M. (2018) · Membranes · doi:10.3390/membranes8010012 · Cited by 94
Gu, G., Hu, Q., Feng, X., Gao, X., Menglin, J., Kang, T., Jiang, D., Song, Q., Chen, H., & Chen, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.022 · Cited by 92
Gelatin Nanoparticles and Their Biofunctionalization
Kommareddy, S., Shenoy, D. B., & Amiji, M. M. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0011 · Cited by 92
Biodegradable Photonic Melanoidin for Theranostic Applications
Lee, M., Lee, C., Jung, H. S., Jeon, M., Kim, K. S., Yun, S. H., Kim, C., & Hahn, S. K. (2015) · ACS Nano · doi:10.1021/acsnano.5b05931 · Cited by 88
Biodegradable Polydisulfide Dendrimer Nanoclusters as MRI Contrast Agents
Huang, C., Nwe, K., Zaki, A. A., Brechbiel, M. W., & Tsourkas, A. (2012) · ACS Nano · doi:10.1021/nn304160p · Cited by 86
Voss, M. H., Hussain, A., Vogelzang, N. J., Lee, J. L., Keam, B., Rha, S. Y., Vaishampayan, U. N., Harris, W. B., Richey, S. L., Randall, J. M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx493 · Cited by 86
Biodegradable Biliverdin Nanoparticles for Efficient Photoacoustic Imaging
Fathi, P., Knox, H. J., Sar, D., Tripathi, I., Ostadhossein, F., Misra, S. K., Esch, M. B., Chan, J., & Pan, D. (2019) · ACS Nano · doi:10.1021/acsnano.9b01201 · Cited by 77
Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species
Binderup, T., Duivenvoorden, R., Fay, F., van Leent, M. M. T., Malkus, J., Baxter, S., Ishino, S., Zhao, Y., Sánchez-Gaytán, B. L., Teunissen, A. J. P., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7736 · Cited by 70
Recent advancements in the cardiovascular drug carriers
Singh, B., Garg, T., Goyal, A. K., & Rath, G. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.937868 · Cited by 69
Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases
Kim, K. S., Song, C. G., & Kang, P. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7428 · Cited by 61
Self-citationPoly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its Immunotoxicity
Silva, J. D., Jesus, S., Bernardi, N. S., Colaço, M., & Borges, O. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00137 · Cited by 56
Wei, R., Jiang, G., Lv, M., Tan, S., Wang, X., Zhou, Y., Cheng, T., Gao, X., Chen, X., Wang, W., et al. (2019) · Theranostics · doi:10.7150/thno.35346 · Cited by 56
Dual-Targeted Synthetic Nanoparticles for Cardiovascular Diseases
Banik, B., Surnar, B., Askins, B. W., Banerjee, M., & Dhar, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b19036 · Cited by 55
Chan, J. M. W., Wojtecki, R. J., Sardón, H., Lee, A. L. Z., Smith, C. E., Shkumatov, A. A., Gao, S., Kong, H., Yang, Y. Y., & Hedrick, J. L. (2017) · ACS Macro Letters · doi:10.1021/acsmacrolett.6b00924 · Cited by 54
Cytotoxicity of Poly(Alkyl Cyanoacrylate) Nanoparticles
Sulheim, E., Iversen, T., Nakstad, V. T., Klinkenberg, G., Sletta, H., Schmid, R., Hatletveit, A. R., Wågbø, A. M., Sundan, A., Skotland, T., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112454 · Cited by 51
Engineering Nanomaterials for Smart Drug Release
Singh, A. K., Yadav, T. P., Pandey, B., Gupta, V., & Singh, S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00015-6 · Cited by 47
Takahama, H., Shigematsu, H., Asai, T., Matsuzaki, T., Sanada, S., Fu, H. Y., Okuda, K., Yamato, M., Asanuma, H., Asano, Y., et al. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6437-6 · Cited by 46
Functionalised collagen spheres reduce H2O2 mediated apoptosis by scavenging overexpressed ROS
Tapeinos, C., Larrañaga, A., Sarasua, J.-R., & Pandit, A. S. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.03.022 · Cited by 43
Low-Fouling and Biodegradable Protein-Based Particles for Thrombus Imaging
Bonnard, T., Jayapadman, A., Putri, J. A. H., Cui, J., Ju, Y., Carmichael, C., Angelovich, T. A., Cody, S. H., French, S. L., Pascaud, K., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02588 · Cited by 41
Xiao, Y., Liu, Q., Clulow, A. J., Li, T., Manohar, M., Gilbert, E. P., de Campo, L., Hawley, A. M., & Boyd, B. J. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110362 · Cited by 37
Micelle-templated, poly(lactic-co-glycolic acid) nanoparticles for hydrophobic drug delivery
Nabar, G., Mahajan, K. D., Calhoun, M. A., Duong, A. D., Souva, M., Xu, J., Czeisler, C. M., Puduvalli, V. K., Otero, J. J., Wyslouzil, B. E., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s142079 · Cited by 35
The Application of Nanomaterials in Stem Cell Therapy for Some Neurological Diseases
Zhang, G., Khan, A. A., Wu, H., Chen, L., Gu, Y., & Gu, N. (2017) · Current Drug Targets · doi:10.2174/1389450118666170328115801 · Cited by 32
Synthesis and Production of Poly(Lactic Acid)
Sin, L. T., & Tueen, B. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814472-5.00002-9 · Cited by 29
Anticoagulant Therapy For Acute Coronary Syndromes
Onwordi, E. N., Gamal, A. S., & Zaman, A. (2018) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2017:26:1 · Cited by 29
Synthesis and Production of Poly(lactic Acid)
Sin, L. T., Rahmat, A. R., & Rahman, W. A. W. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-4459-0.00002-0 · Cited by 23
Nanoparticles for Postinfarct Ventricular Remodeling
Dong, C., Ma, A., & Shang, L. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0264 · Cited by 22
Biodegradable Nanoparticles for Drug Delivery and Targeting
Wiwanitkit, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-06115-9_9 · Cited by 16
Safari, M., Kamari, Y., Ghiaci, M., Sadeghi‐Aliabadi, H., & Mirian, M. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1220573 · Cited by 14
Polymeric micelles as a versatile tool in oral chemotherapy
Ribeiro, A. M., Amaral, C., Veiga, F., & Figueiras, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00008-9 · Cited by 11
Cited by
Biopolymer: A Sustainable Material for Food and Medical Applications
Baranwal, J., Barse, B., Fais, A., Delogu, G. L., & Kumar, A. (2022) · Polymers · doi:10.3390/polym14050983 · Cited by 727
Harish, V., Tewari, D., Gaur, M., Yadav, A. B., Swaroop, S., Bechelany, M., & Barhoum, A. (2022) · Nanomaterials · doi:10.3390/nano12030457 · Cited by 623
Drug release study of the chitosan-based nanoparticles
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2021.e08674 · Cited by 576
“CSNPs are used for developing the stimuli-responsive NPs to carry chemo drugs to deliver specifically at cancer locations without causing any toxicity to normal cells [72].”
BackgroundBiodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Clinical translation of nanomedicines: Challenges, opportunities, and keys
Younis, M. A., Tawfeek, H. M., Abdellatif, A. A. H., Abdel-Aleem, J. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114083 · Cited by 462
Metadata
- Authors
- Su, S., & Kang, P. M.
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2020-04-01
- Volume
- 10
- Issue
- 4
- Pages
- 656
- ISSN
- 2079-4991 (ISSN-L)
- OpenAlex
- W3014631388
- Cited by
- 312
- References
- 120
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.